Advertisement

Lymphoblastic Leukemia/Lymphoma

  • Qian-Yun ZhangEmail author
Chapter
Part of the Atlas of Anatomic Pathology book series (AAP)

Abstract

Lymphoblastic leukemia/lymphoma (i.e., acute lymphoblastic leukemia/lymphoma or ALL) is the most common type of cancer in childhood. The age-adjusted incidence rate is 3.1/100,000 in children, so approximately 2500–3000 children are diagnosed with acute lymphoblastic leukemia (ALL) each year in the United States). Approximately 80–85% of the cases are B-ALL and 10–15% are T-ALL (Table 9.1). Approximately 75% of ALL occurs in children under 6 years old, but it can occur at any age [1, 2]. Patients typically present with anemia, thrombocytopenia, and/or neutropenia-related signs and symptoms such as fatigue, weakness, shortness of breath, easy bruising, bleeding, and infection. Genetic factors play important roles in cancer initiation. Age, WBC count at disease presentation and genetic aberrations dictate risk stratification.

Keywords

Acute lymphoblastic leukemia/lymphoma B lymphoblasts T lymphoblasts Recurrent genetic abnormalities 

References

  1. 1.
    Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. IARC: Lyon; 2008. p. 168–78.Google Scholar
  2. 2.
    Bassan R, Maino E, Cortelazzo S. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment. Eur J Haematol. 2016;96:447–60. https://doi.org/10.1111/ejh.12722.CrossRefPubMedGoogle Scholar
  3. 3.
    Moriyama T. Familial acute lymphoblastic leukemia. Rinsho Ketsueki. 2016;57:900–9. 10.11406/rinketsu.57.900.PubMedGoogle Scholar
  4. 4.
    Pulte D, Gondos A, Brenner H. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood. 2009;113:1408–11. https://doi.org/10.1182/blood-2008-06-164863.CrossRefPubMedGoogle Scholar
  5. 5.
    Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. 2012;120:1165–74. https://doi.org/10.1182/blood-2012-05-378943.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Madhusoodhan PP, Carroll WL, Bhatla T. Progress and prospects in pediatric leukemia. Curr Probl Pediatr Adolesc Health Care. 2016;46:229–41. https://doi.org/10.1016/j.cppeds.2016.04.003.CrossRefPubMedGoogle Scholar
  7. 7.
    Sorensen JT, Gerald K, Bodensteiner D, Holmes FF. Effect of age on survival in acute leukemia. 1950-1990. Cancer. 1993;72:1602–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Irken G, Oren H, Gülen H, Duman M, Uçar C, Atabay B, et al. Treatment outcome of adolescents with acute lymphoblastic leukemia. Ann Hematol. 2002;81:641–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Jacobson S, Tedder M, Eggert J. Adult acute lymphoblastic leukemia: a genetic overview and application to clinical practice. Clin J Oncol Nurs. 2016;20:E147–54.CrossRefPubMedGoogle Scholar
  10. 10.
    Paul S, Kantarjian H, Jabbour EJ. Adult acute lymphoblastic leukemia. Mayo Clin Proc. 2016;91:1645–66. https://doi.org/10.1016/j.mayocp.2016.09.010.CrossRefPubMedGoogle Scholar
  11. 11.
    Guest EM, Stam RW. Updates in the biology and therapy for infant acute lymphoblastic leukemia. Curr Opin Pediatr. 2017;29:20–6. https://doi.org/10.1097/MOP.0000000000000437.CrossRefPubMedGoogle Scholar
  12. 12.
    Safavi S, Paulsson K. Near-haploid and low-hypodiploid acute lymphoblastic leukemia: two distinct subtypes with consistently poor prognosis. Blood. 2017;129:420–3. https://doi.org/10.1182/blood-2016-10-743765.CrossRefPubMedGoogle Scholar
  13. 13.
    Bhojwani D, Kang H, Menezes RX, Yang W, Sather H, Moskowitz NP, et al.; Children’s Oncology Group Study; Dutch Childhood Oncology Group; German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia. Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: a Children’s Oncology Group Study [corrected]. J Clin Oncol 2008;26:4376–4384. doi: https://doi.org/10.1200/JCO.2007.14.4519
  14. 14.
    Moorman AV, Schwab C, Ensor HM, Russell LJ, Morrison H, Jones L, et al. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. J Clin Oncol. 2012;30:3100–8. https://doi.org/10.1200/JCO.2011.40.3907.CrossRefPubMedGoogle Scholar
  15. 15.
    Roberts KG, Morin RD, Zhang J, Hirst M, Zhao Y, Su X, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012;22:153–66. https://doi.org/10.1016/j.ccr.2012.06.005.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Mullighan CG. The genomic landscape of acute lymphoblastic leukemia in children and young adults. Hematology Am Soc Hematol Educ Program. 2014;2014(1):174–80. https://doi.org/10.1182/asheducation-2014.1.174.PubMedGoogle Scholar
  17. 17.
    Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371:1005–15. https://doi.org/10.1056/NEJMoa1403088.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Boer JM, Steeghs EM, Marchante JR, Boeree A, Beaudoin JJ, Beverloo HB, et al. Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia. Oncotarget. 2017;8:4618–28. 10.18632/oncotarget.13492.CrossRefPubMedGoogle Scholar
  19. 19.
    Den Boer ML, van Slegtenhorst M, De Menezes RX, Cheok MH, Buijs-Gladdines JG, Peters ST, et al. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol. 2009;10:125–34. https://doi.org/10.1016/S1470-2045(08)70339-5.CrossRefGoogle Scholar
  20. 20.
    Jain N, Roberts KG, Jabbour E, Patel K, Eterovic AK, Chen K, et al. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood. 2017;129:572–81. https://doi.org/10.1182/blood-2016-07-726588.CrossRefPubMedGoogle Scholar
  21. 21.
    Roberts KG, Gu Z, Payne-Turner D, McCastlain K, Harvey RC, Chen IM, et al. High frequency and poor outcome of Philadelphia chromosome–like acute lymphoblastic leukemia in adults. J Clin Oncol. 2017;35:394–401. https://doi.org/10.1200/JCO.2016.69.0073.CrossRefPubMedGoogle Scholar
  22. 22.
    Ryan SL, Matheson E, Grossmann V, Sinclair P, Bashton M, Schwab C, et al. The role of the RAS pathway in iAMP21-ALL. Leukemia. 2016;30:1824–31. https://doi.org/10.1038/leu.2016.80.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Buitenkamp TD, Izraeli S, Zimmermann M, Forestier E, Heerema NA. van den Heuvel-Eibrink MM, et al. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group. Blood. 2014;123:70–7. https://doi.org/10.1182/blood-2013-06-509463.
  24. 24.
    Lee P, Bhansali R, Izraeli S, Hijiya N, Crispino JD. The biology, pathogenesis and clinical aspects of acute lymphoblastic leukemia in children with Down syndrome. Leukemia. 2016;30:1816–23. https://doi.org/10.1038/leu.2016.164.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Zhang L, Ramjit RT, Hill CE, Arellano M, Khoury HJ, Mann KP. Clinical significance of quantitative monitoring and mutational analysis of BCR-ABL1 transcript in Philadelphia chromosome positive B lymphoblastic leukemia. Leuk Lymphoma. 2015;57:364–9. https://doi.org/10.3109/10428194.2014.1003059.CrossRefGoogle Scholar
  26. 26.
    Short NJ, Jabbour E, Sasaki K, Patel K, O’Brien SM, Cortes JE, et al. Impact of complete molecular response on survival in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia. Blood. 2016;128:504–7. https://doi.org/10.1182/blood-2016-03-707562.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Belver L, Ferrando A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2016;16:494–507. https://doi.org/10.1038/nrc.2016.63.CrossRefPubMedGoogle Scholar
  28. 28.
    Karrman K, Johansson B. Pediatric T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2017;56:89–116. https://doi.org/10.1002/gcc.22416.CrossRefPubMedGoogle Scholar
  29. 29.
    Heerema NA, Sather HN, Sensel MG, Kraft P, Nachman JB, Steinherz PG, et al. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children’s Cancer Group. J Clin Oncol. 1998;16:1270–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Schneider NR, Carroll AJ, Shuster JJ, Pullen DJ, Link MP, Borowitz MJ, et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood. 2000;96:2543–9.PubMedGoogle Scholar
  31. 31.
    Karrman K, Forestier E, Heyman M, Andersen MK, Autio K, Blennow E, et al. Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome. Genes Chromosomes Cancer. 2009;48:795–805. https://doi.org/10.1002/gcc.20684.CrossRefPubMedGoogle Scholar
  32. 32.
    Girardi T, Vicente C, Cools J, De Keersmaecker K. The genetics and molecular biology of T-ALL. Blood. 2017;129:1113–23. https://doi.org/10.1182/blood-2016-10-706465.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Reichard K. Precursor B- and T-cell acute lymphoblastic leukemia/lymphoma (aka lymphoblastic leukemia/lymphoma). In: Foucar K, Reichard K, Czuchlewski D, editors. Bone marrow pathology. 3rd ed. Chicago: ASCP; 2010. p. 591–615.Google Scholar
  34. 34.
    Suzuki S, Nagel S, Schneider B, Chen S, Kaufmann M, Uozumi K, et al. A second NOTCH1 chromosome rearrangement: t(9;14)(q34.3;q11.2) in T-cell neoplasia. Leukemia. 2009;23:1003–6. https://doi.org/10.1038/leu.2008.366.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2018

Authors and Affiliations

  1. 1.Department of PathologyUniversity of New MexicoAlbuquerqueUSA

Personalised recommendations